Clinical Trials Browser

Suspended × Advanced Solid Tumors × Other solid neoplasm × Clear all

NCT05571969 2025-05-07

Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors

Phase 1 Suspended

Other solid neoplasm

Advanced Solid Tumors

NCT01226056 2010-10-21

Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets

Phase 1/2 Suspended

Other solid neoplasm

Advanced Solid Tumors